MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma
Clinical trial NCT03773744 · WITHDRAWN
Trial details
- NCT number
- NCT03773744
- Sponsor
- Turnstone Biologics, Corp.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-15
- Primary completion
- 2020-10-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.